EscharEx (5% EX-02 formulation) + Gel Vehicle + Non-surgical standard of care (NSSOC)
Phase 2Completed 0 watching 0 views this week⚡ Active
44
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Venous Leg Ulcer
Conditions
Venous Leg Ulcer
Trial Timeline
Dec 2, 2019 → Mar 23, 2022
NCT ID
NCT03588130About EscharEx (5% EX-02 formulation) + Gel Vehicle + Non-surgical standard of care (NSSOC)
EscharEx (5% EX-02 formulation) + Gel Vehicle + Non-surgical standard of care (NSSOC) is a phase 2 stage product being developed by MediWound for Venous Leg Ulcer. The current trial status is completed. This product is registered under clinical trial identifier NCT03588130. Target conditions include Venous Leg Ulcer.
Hype Score Breakdown
Clinical
17
Activity
12
Company
2
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03588130 | Phase 2 | Completed |
Competing Products
20 competing products in Venous Leg Ulcer